A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors

Clinical trial NCT07600476 · RECRUITING

Trial details

NCT number: NCT07600476
Sponsor: Kupando GmbH
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Cutaneous Melanoma Mucosal Melanoma Cutaneous Squamous Cell Carcinoma (CSCC)Merkel Cell Carcinoma of Skin Basal Cell Carcinoma of Skin

Start date: 2026-07-03
Primary completion: 2028-12-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.